Cargando…

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease

Frequent acute exacerbations are the leading cause of high rates of hospitalization and mortality in chronic obstructive pulmonary disease (COPD). Despite the enormous worldwide medical burden, reliable molecular markers for effective early diagnosis and prognosis of acute exacerbations are still la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Linfan, Qiao, Yixian, Luo, Jinmei, Huang, Rong, Xiao, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599557/ https://www.ncbi.nlm.nih.gov/pubmed/36291689 http://dx.doi.org/10.3390/biom12101481

Ejemplares similares

Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices
por: Su, Linfan, et al.
Publicado: (2022)

Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability
por: Dang, Xiaomin, et al.
Publicado: (2022)

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease
por: Manjhi, Rekha, et al.
Publicado: (2022)

Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease
por: Liu, Hai-Yue, et al.
Publicado: (2017)

Could the Sputum Microbiota Be a Biomarker That Predicts Mortality after Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
por: Tsay, Jun-Chieh J., et al.
Publicado: (2019)

Sputum Inflammometry to Manage Chronic Obstructive Pulmonary Disease Exacerbations: Beyond Guidelines
por: Venegas, Carmen, et al.
Publicado: (2020)

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
por: Qi, Yu-Jing, et al.
Publicado: (2020)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
por: Wedzicha, Jadwiga A, et al.
Publicado: (2013)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease
por: Diao, Wenqi, et al.
Publicado: (2018)

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
por: Hasegawa, Kohei, et al.
Publicado: (2014)

Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
por: McCullagh, Brian N., et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
por: Uslu, Berat, et al.
Publicado: (2022)

Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Gao, Peng, et al.
Publicado: (2013)

Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease
por: Yang, Chengyu, et al.
Publicado: (2023)

Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2010)

Relationship between Periodontitis-Related Antibody and Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Takahashi, Tamaki, et al.
Publicado: (2012)

Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease
por: Chang, Chun, et al.
Publicado: (2014)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2015)

The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population
por: Liu, Dan, et al.
Publicado: (2023)

Markers of exacerbation severity in chronic obstructive pulmonary disease
por: Franciosi, Luigi G, et al.
Publicado: (2006)

Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora
por: Ke, Li, et al.
Publicado: (2022)

Clinical and pulmonary functions profiling of patients with chronic obstructive pulmonary disease experiencing frequent acute exacerbations
por: Gupta, Prem Parkash, et al.
Publicado: (2018)

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort
por: Singh, Dave, et al.
Publicado: (2014)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state
por: Yang, Chia-Yu, et al.
Publicado: (2021)

“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease
por: Tomioka, Ryusuke, et al.
Publicado: (2016)

A search for covert precipitating clinical parameters in frequent exacerbators of chronic obstructive pulmonary disease
por: Bhatia, Ankit, et al.
Publicado: (2016)

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
por: Talman, Sander, et al.
Publicado: (2021)

Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study
por: Mohan, Sindu, et al.
Publicado: (2017)

Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease
por: Qiu, Weiliang, et al.
Publicado: (2011)

The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review
por: Wu, Jian-jun, et al.
Publicado: (2020)

Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
por: Dreyse, Jorge, et al.
Publicado: (2015)

Impaired Blood Neutrophil Function in the Frequent Exacerbator of Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study
por: Jones, Arwel Wyn, et al.
Publicado: (2016)

Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations
por: Cuevas, Ester, et al.
Publicado: (2023)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_0kea9vvvqrn208o50cd24cf2ec